| pubmed-article:20068559 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0012155 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0087163 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C1515075 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0936233 | lld:lifeskim |
| pubmed-article:20068559 | lifeskim:mentions | umls-concept:C0336791 | lld:lifeskim |
| pubmed-article:20068559 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20068559 | pubmed:dateCreated | 2010-6-4 | lld:pubmed |
| pubmed-article:20068559 | pubmed:abstractText | Nonalcoholic steatohepatitis (NASH) is a known metabolic disorder of the liver. No treatment has been conclusively shown to improve NASH or prevent disease progression. The function of L-carnitine to modulate lipid profile, glucose metabolism, oxidative stress, and inflammatory responses has been shown. The aim of this study was to evaluate the effects of L-carnitine's supplementation on regression of NASH. | lld:pubmed |
| pubmed-article:20068559 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20068559 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20068559 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20068559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20068559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20068559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20068559 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20068559 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20068559 | pubmed:issn | 1572-0241 | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:MalaguarneraM... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:Li... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:AvitabileTere... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:GalvanoFabioF | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:RussoCristina... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:GarganteMaria... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:MalaguarneraM... | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:VacanteMarcoM | lld:pubmed |
| pubmed-article:20068559 | pubmed:author | pubmed-author:AnticTijanaT | lld:pubmed |
| pubmed-article:20068559 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20068559 | pubmed:volume | 105 | lld:pubmed |
| pubmed-article:20068559 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20068559 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20068559 | pubmed:pagination | 1338-45 | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:meshHeading | pubmed-meshheading:20068559... | lld:pubmed |
| pubmed-article:20068559 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20068559 | pubmed:articleTitle | L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial. | lld:pubmed |
| pubmed-article:20068559 | pubmed:affiliation | Department of Senescence, Urological and Neurological Sciences, University of Catania, Catania, Italy. malaguar@unict.it | lld:pubmed |
| pubmed-article:20068559 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20068559 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20068559 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
